학술논문
First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study
Document Type
Article
Author
Lee, Siow Ming ; Schulz, Christian; Prabhash, Kumar; Kowalski, Dariusz; Szczesna, Aleksandra; Han, Baohui; Rittmeyer, Achim; Talbot, Toby; Vicente, David; Califano, Raffaele; Cortinovis, Diego; Le, Anh Tuan; Huang, Dingzhi; Liu, Geoffrey; Cappuzzo, Federico; Reyes Contreras, Jessica; Reck, Martin; Palmero, Ramon; Mak, Milena Perez; Hu, Youyou; Morris, Stefanie; Höglander, Elen; Connors, Mary; Biggane, Alice M; Vollan, Hans Kristian; Peters, Solange
Source
In The Lancet 5-11 August 2023 402(10400):451-463
Subject
Language
ISSN
0140-6736